BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death - PubMed (original) (raw)
Comparative Study
. 2007 Apr;37(4):990-1000.
doi: 10.1002/eji.200636698.
Affiliations
- PMID: 17357108
- DOI: 10.1002/eji.200636698
Free article
Comparative Study
BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death
Eva V Acosta-Rodríguez et al. Eur J Immunol. 2007 Apr.
Free article
Abstract
Microorganisms with pathogen-associated molecular patterns (PAMP) activate B cells directly by binding to TLR and also indirectly by inducing APC to release cytokines such as BAFF that promote B cell survival. We found that murine B cells activated concomitantly with LPS (TLR-4 ligand) and BAFF are protected from spontaneous apoptosis, but are more susceptible to Fas/CD95-mediated cell death. This increased susceptibility to Fas-induced apoptosis is associated with a dramatic coordinated up-regulation of Fas/CD95 and IRF-4 expression through a mechanism mediated, at least in part, by inhibition of the MEK/ERK pathway. Up-regulation of Fas/CD95 by BAFF is restricted to B cells activated through TLR-4, but not through TLR-9, BCR or CD40. TLR ligands differ in the BAFF family receptors (R) they induce on B cells: BAFF-R is increased by the TLR4 ligand, LPS, but not by the TLR9 ligand, CpG-containing oligodeoxynucleotides, which, in contrast, strongly up-regulates transmembrane activator and CAML interactor (TACI). This suggests the up-regulation of Fas by BAFF is mediated by BAFF-R and not by TACI. Consistently, APRIL, which binds to TACI and B cell maturation antigen but not BAFF-R, did not enhance Fas expression on LPS-activated B cells. Increased susceptibility to Fas-mediated killing of B cells activated with LPS and BAFF may be a fail-safe mechanism to avoid overexpansion of nonspecific or autoreactive B cells.
Similar articles
- TACI attenuates antibody production costimulated by BAFF-R and CD40.
Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T. Sakurai D, et al. Eur J Immunol. 2007 Jan;37(1):110-8. doi: 10.1002/eji.200636623. Eur J Immunol. 2007. PMID: 17154264 - Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M. Katsenelson N, et al. Eur J Immunol. 2007 Jul;37(7):1785-95. doi: 10.1002/eji.200636800. Eur J Immunol. 2007. PMID: 17557373 - TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor.
Hayashi EA, Granato A, Paiva LS, Bertho AL, Bellio M, Nobrega A. Hayashi EA, et al. J Immunol. 2010 May 1;184(9):4662-72. doi: 10.4049/jimmunol.0903253. Epub 2010 Mar 31. J Immunol. 2010. PMID: 20357250 - BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C, Schneider P. Bossen C, et al. Semin Immunol. 2006 Oct;18(5):263-75. doi: 10.1016/j.smim.2006.04.006. Epub 2006 Aug 17. Semin Immunol. 2006. PMID: 16914324 Review. - TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F, Schneider P. Mackay F, et al. Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76. doi: 10.1016/j.cytogfr.2008.04.006. Epub 2008 Jun 2. Cytokine Growth Factor Rev. 2008. PMID: 18514565 Review.
Cited by
- Virulence and Immune Evasion Strategies of FMDV: Implications for Vaccine Design.
Medina GN, Diaz San Segundo F. Medina GN, et al. Vaccines (Basel). 2024 Sep 19;12(9):1071. doi: 10.3390/vaccines12091071. Vaccines (Basel). 2024. PMID: 39340101 Free PMC article. Review. - IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway.
Zhu Y, He H, Sun W, Wu J, Xiao Y, Peng Y, Hu P, Jin M, Liu P, Zhang D, Xie T, Huang L, He W, Wei M, Wang L, Xu X, Tang Y. Zhu Y, et al. Nephrol Dial Transplant. 2024 Sep 27;39(10):1624-1641. doi: 10.1093/ndt/gfae052. Nephrol Dial Transplant. 2024. PMID: 38402460 Free PMC article. - The emerging roles and therapeutic potential of B cells in sepsis.
Ma C, Liu H, Yang S, Li H, Liao X, Kang Y. Ma C, et al. Front Pharmacol. 2022 Nov 8;13:1034667. doi: 10.3389/fphar.2022.1034667. eCollection 2022. Front Pharmacol. 2022. PMID: 36425582 Free PMC article. Review. - Ligation of TLR Homologue CD180 of B Cells Activates the PI3K/Akt/mTOR Pathway in Systemic Sclerosis and Induces a Pathological Shift in the Expression of BAFF Receptors.
Erdő-Bonyár S, Rapp J, Szinger D, Minier T, Kumánovics G, Czirják L, Berki T, Simon D. Erdő-Bonyár S, et al. Int J Mol Sci. 2022 Jun 17;23(12):6777. doi: 10.3390/ijms23126777. Int J Mol Sci. 2022. PMID: 35743222 Free PMC article. - B-cell dynamics during experimental endotoxemia in humans.
Brinkhoff A, Zeng Y, Sieberichs A, Dolff S, Shilei X, Sun M, Engler H, Benson S, Korth J, Schedlowski M, Kribben A, Witzke O, Wilde B. Brinkhoff A, et al. Biosci Rep. 2019 May 17;39(5):BSR20182347. doi: 10.1042/BSR20182347. Print 2019 May 31. Biosci Rep. 2019. PMID: 30962268 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous